Skip to main content
Top
Published in: Endocrine 1/2011

01-08-2011 | Original Article

Influence of diabetes mellitus on vertebral fractures in men with acromegaly

Authors: Gherardo Mazziotti, Monica Gola, Antonio Bianchi, Teresa Porcelli, Antonella Giampietro, Vincenzo Cimino, Mauro Doga, Carmine Gazzaruso, Laura De Marinis, Andrea Giustina

Published in: Endocrine | Issue 1/2011

Login to get access

Abstract

Acromegaly is frequently complicated by fragility vertebral fractures and diabetes mellitus. Since type 2 diabetes mellitus is a cause of secondary osteoporosis in the general population, in this cross-sectional study we aimed at investigating the association between diabetes mellitus and vertebral fractures in males with acromegaly. Fifty-seven patients (median age 47 years, range: 24–85) with active (21 cases) and controlled (36 cases) acromegaly and 57 control subjects were evaluated for bone mineral density (BMD) by DXA and vertebral fractures by a quantitative morphometric analysis. Diabetes mellitus was found in 18 patients and 18 control subjects. The prevalence of vertebral fractures was higher in acromegalic patients as compared with the control subjects (50.9 vs. 10.5%; χ2: 21.8; P < 0.001). Acromegalic patients with fractures had serum IGF-I values significantly higher (P = 0.009), longer duration of active disease (P < 0.001) and higher prevalence of active acromegaly (P = 0.007) and diabetes mellitus (P = 0.04) as compared to patients who did not fracture. When acromegaly was active, the prevalence of vertebral fractures was high independently of the coexistent diabetes mellitus. On the contrary, when acromegaly was controlled the prevalence of vertebral fractures was significantly higher in patients with diabetes as compared to patients without diabetes (62.6 vs. 28.0%; P = 0.04). In both diabetic and non diabetic patients, vertebral fractures occurred independently of BMD. In conclusion, this study suggests that diabetes mellitus may be associated with an increased prevalence of vertebral fractures in males with acromegaly. However, this effect seems to be relatively attenuated in the presence of persistent GH hypersecretion.
Literature
1.
go back to reference A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)PubMedCrossRef A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)PubMedCrossRef
2.
go back to reference E. Canalis, A. Giustina, J.P. Bilezikian, Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med. 35, 7905–7916 (2007) E. Canalis, A. Giustina, J.P. Bilezikian, Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med. 35, 7905–7916 (2007)
3.
go back to reference S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res. 20, 1837–1844 (2005)PubMedCrossRef S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res. 20, 1837–1844 (2005)PubMedCrossRef
4.
go back to reference G. Mazziotti, A. Bianchi, S. Bonadonna, V. Cimino, I. Patelli, A. Fusco, A. Pontecorvi, L. De Marinis, A. Giustina, Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93, 4649–4655 (2008)PubMedCrossRef G. Mazziotti, A. Bianchi, S. Bonadonna, V. Cimino, I. Patelli, A. Fusco, A. Pontecorvi, L. De Marinis, A. Giustina, Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93, 4649–4655 (2008)PubMedCrossRef
5.
go back to reference M.J. Wassenaar, N.R. Biermasz, N.A. Hamdy, M.C. Zillikens, J.B. van Meurs, F. Rivadeneira, A. Hofman, A.G. Uitterlinden, M.P. Stokkel, F. Roelfsema, M. Kloppenburg, H.M. Kroon, J.A. Romijn, A.M. Pereira, High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur. J. Endocrinol. 164, 475–483 (2011)PubMedCrossRef M.J. Wassenaar, N.R. Biermasz, N.A. Hamdy, M.C. Zillikens, J.B. van Meurs, F. Rivadeneira, A. Hofman, A.G. Uitterlinden, M.P. Stokkel, F. Roelfsema, M. Kloppenburg, H.M. Kroon, J.A. Romijn, A.M. Pereira, High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur. J. Endocrinol. 164, 475–483 (2011)PubMedCrossRef
6.
go back to reference A. Giustina, F.F. Casanueva, F. Cavagnini, P. Chanson, D. Clemmons, L.A. Frohman, R. Gaillard, K. Ho, P. Jaquet, D.L. Kleinberg, S.W. Lamberts, G. Lombardi, M. Sheppard, C.J. Strasburger, M.L. Vance, J.A. Wass, S. Melmed, Pituitary Society and the European Neuroendocrine Association, Diagnosis and treatment of acromegaly complications. J. Endocrinol. Invest. 26, 1242–1247 (2003)PubMed A. Giustina, F.F. Casanueva, F. Cavagnini, P. Chanson, D. Clemmons, L.A. Frohman, R. Gaillard, K. Ho, P. Jaquet, D.L. Kleinberg, S.W. Lamberts, G. Lombardi, M. Sheppard, C.J. Strasburger, M.L. Vance, J.A. Wass, S. Melmed, Pituitary Society and the European Neuroendocrine Association, Diagnosis and treatment of acromegaly complications. J. Endocrinol. Invest. 26, 1242–1247 (2003)PubMed
7.
go back to reference G. Mazziotti, S. Bonadonna, M. Doga, I. Patelli, C. Gazzaruso, S.B. Solerte, E. De Menis, A. Giustina, Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. Neuroendocrinology 88, 299–304 (2008)PubMedCrossRef G. Mazziotti, S. Bonadonna, M. Doga, I. Patelli, C. Gazzaruso, S.B. Solerte, E. De Menis, A. Giustina, Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. Neuroendocrinology 88, 299–304 (2008)PubMedCrossRef
8.
go back to reference G. Mazziotti, I. Floriani, S. Bonadonna, V. Torri, P. Chanson, A. Giustina, Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J. Clin. Endocrinol. Metab. 94, 1500–1508 (2009)PubMedCrossRef G. Mazziotti, I. Floriani, S. Bonadonna, V. Torri, P. Chanson, A. Giustina, Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J. Clin. Endocrinol. Metab. 94, 1500–1508 (2009)PubMedCrossRef
9.
go back to reference A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr. Rev. 25, 102–152 (2004)PubMedCrossRef A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr. Rev. 25, 102–152 (2004)PubMedCrossRef
10.
go back to reference M.L. Jaffrain-Rea, C. Moroni, R. Baldelli, C. Battista, P. Maffei, M. Terzolo, M. Correra, M.R. Ghiggi, E. Ferretti, A. Angeli, N. Sicolo, V. Trischitta, A. Liuzzi, R. Cassone, G. Tamburrano, Relationship between blood pressure and glucose tolerance in acromegaly. Clin. Endocrinol. (Oxf.) 54, 189–195 (2001)CrossRef M.L. Jaffrain-Rea, C. Moroni, R. Baldelli, C. Battista, P. Maffei, M. Terzolo, M. Correra, M.R. Ghiggi, E. Ferretti, A. Angeli, N. Sicolo, V. Trischitta, A. Liuzzi, R. Cassone, G. Tamburrano, Relationship between blood pressure and glucose tolerance in acromegaly. Clin. Endocrinol. (Oxf.) 54, 189–195 (2001)CrossRef
11.
go back to reference A. Räkel, O. Sheehy, E. Rahme, J. LeLorier, Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab. 34, 193–205 (2008)PubMedCrossRef A. Räkel, O. Sheehy, E. Rahme, J. LeLorier, Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab. 34, 193–205 (2008)PubMedCrossRef
12.
go back to reference P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos. Int. 18, 427–444 (2007)PubMedCrossRef P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos. Int. 18, 427–444 (2007)PubMedCrossRef
13.
go back to reference T. Mancini, G. Mazziotti, M. Doga, R. Carpinteri, N. Simetovic, P.P. Vescovi, A. Giustina, Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45, 784–788 (2009)PubMedCrossRef T. Mancini, G. Mazziotti, M. Doga, R. Carpinteri, N. Simetovic, P.P. Vescovi, A. Giustina, Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45, 784–788 (2009)PubMedCrossRef
14.
go back to reference A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000)PubMedCrossRef A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000)PubMedCrossRef
15.
go back to reference A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, Acromegaly Consensus Group, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)PubMedCrossRef A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, Acromegaly Consensus Group, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)PubMedCrossRef
16.
17.
go back to reference S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg, D. Clemmons, P. Chanson, E. Laws, J. Schlechte, M.L. Vance, K. Ho, A. Giustina, Acromegaly Consensus Group, Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509–1517 (2009)PubMedCrossRef S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg, D. Clemmons, P. Chanson, E. Laws, J. Schlechte, M.L. Vance, K. Ho, A. Giustina, Acromegaly Consensus Group, Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509–1517 (2009)PubMedCrossRef
18.
go back to reference American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1), S62–S69 (2011)CrossRef American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1), S62–S69 (2011)CrossRef
19.
go back to reference A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)PubMedCrossRef A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)PubMedCrossRef
20.
go back to reference G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123, 877–884 (2010)PubMedCrossRef G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123, 877–884 (2010)PubMedCrossRef
21.
go back to reference H.K. Genant, M. Jergas, L. Palermo, M. Nevitt, R.S. Valentin, D. Black, S.R. Cummings, Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11, 984–996 (1996)PubMedCrossRef H.K. Genant, M. Jergas, L. Palermo, M. Nevitt, R.S. Valentin, D. Black, S.R. Cummings, Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11, 984–996 (1996)PubMedCrossRef
22.
go back to reference G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21, 520–528 (2006)PubMedCrossRef G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21, 520–528 (2006)PubMedCrossRef
23.
go back to reference S. Ezzat, S. Melmed, D. Endres, D.R. Eyre, F.R. Singer, Biochemical assessment of bone formation and resorption in acromegaly. J. Clin. Endocrinol. Metab. 76, 1452–1457 (1993)PubMedCrossRef S. Ezzat, S. Melmed, D. Endres, D.R. Eyre, F.R. Singer, Biochemical assessment of bone formation and resorption in acromegaly. J. Clin. Endocrinol. Metab. 76, 1452–1457 (1993)PubMedCrossRef
24.
go back to reference T. Ueland, E.N. Ebbesen, J.S. Thomsen, L. Mosekilde, K. Brixen, A. Flyvbjerg, J. Bollerslev, Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur. J. Clin. Invest. 32, 122–128 (2002)PubMedCrossRef T. Ueland, E.N. Ebbesen, J.S. Thomsen, L. Mosekilde, K. Brixen, A. Flyvbjerg, J. Bollerslev, Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur. J. Clin. Invest. 32, 122–128 (2002)PubMedCrossRef
25.
go back to reference C. Battista, I. Chiodini, S. Muscarella, G. Guglielmi, M.L. Mascia, V. Carnevale, A. Scillitani, Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin. Endocrinol. (Oxf.) 70, 378–382 (2009)CrossRef C. Battista, I. Chiodini, S. Muscarella, G. Guglielmi, M.L. Mascia, V. Carnevale, A. Scillitani, Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin. Endocrinol. (Oxf.) 70, 378–382 (2009)CrossRef
26.
go back to reference M.J. Wassenaar, N.R. Biermasz, J. Bijsterbosch, A.M. Pereira, I. Meulenbelt, J.W. Smit, F. Roelfsema, H.M. Kroon, J.A. Romijn, M. Kloppenburg, Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann. Rheum. Dis. 70, 320–325 (2011)PubMedCrossRef M.J. Wassenaar, N.R. Biermasz, J. Bijsterbosch, A.M. Pereira, I. Meulenbelt, J.W. Smit, F. Roelfsema, H.M. Kroon, J.A. Romijn, M. Kloppenburg, Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann. Rheum. Dis. 70, 320–325 (2011)PubMedCrossRef
27.
go back to reference G.P. Lesse, W.D. Fraser, R. Farquharson, L. Hipkin, J.P. Vora, Gonadal status is an important determinant of bone density in acromegaly. Clin. Endocrinol. (Oxf.) 48, 59–65 (1998)CrossRef G.P. Lesse, W.D. Fraser, R. Farquharson, L. Hipkin, J.P. Vora, Gonadal status is an important determinant of bone density in acromegaly. Clin. Endocrinol. (Oxf.) 48, 59–65 (1998)CrossRef
28.
go back to reference A. Scillitani, C. Battista, I. Chiodini, V. Carnevale, S. Fusilli, E. Ciccarelli, M. Terzolo, G. Oppizzi, M. Arosio, M. Gasperi, G. Arnaldi, A. Colao, R. Baldelli, M.R. Ghiggi, D. Gaia, C. Di Somma, V. Trischitta, A. Liuzzi, Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin. Endocrinol. (Oxf.) 58, 725–731 (2003)CrossRef A. Scillitani, C. Battista, I. Chiodini, V. Carnevale, S. Fusilli, E. Ciccarelli, M. Terzolo, G. Oppizzi, M. Arosio, M. Gasperi, G. Arnaldi, A. Colao, R. Baldelli, M.R. Ghiggi, D. Gaia, C. Di Somma, V. Trischitta, A. Liuzzi, Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin. Endocrinol. (Oxf.) 58, 725–731 (2003)CrossRef
29.
go back to reference T.L. Clemens, G. Karsenty, The osteoblast: an insulin target cell controlling glucose homeostasis. J. Bone Miner. Res. 26, 677–680 (2011)PubMedCrossRef T.L. Clemens, G. Karsenty, The osteoblast: an insulin target cell controlling glucose homeostasis. J. Bone Miner. Res. 26, 677–680 (2011)PubMedCrossRef
30.
go back to reference C.J. Rosen, K.J. Motyl, No bones about it: insulin modulates skeletal remodeling. Cell 142, 98–200 (2010)CrossRef C.J. Rosen, K.J. Motyl, No bones about it: insulin modulates skeletal remodeling. Cell 142, 98–200 (2010)CrossRef
31.
go back to reference N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Z. Zhang, J.K. Kim, F. Mauvais-Jarvis, P. Ducy, G. Karsenty, Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456–469 (2007)PubMedCrossRef N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Z. Zhang, J.K. Kim, F. Mauvais-Jarvis, P. Ducy, G. Karsenty, Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456–469 (2007)PubMedCrossRef
32.
go back to reference J.M. Gimble, M.E. Nuttall, Bone and fat: old questions, new insights. Endocrine 23, 183–188 (2004)PubMedCrossRef J.M. Gimble, M.E. Nuttall, Bone and fat: old questions, new insights. Endocrine 23, 183–188 (2004)PubMedCrossRef
33.
go back to reference K. Ağbaht, A. Gürlek, J. Karakaya, M. Bayraktar, Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine 35, 371–379 (2009)PubMedCrossRef K. Ağbaht, A. Gürlek, J. Karakaya, M. Bayraktar, Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine 35, 371–379 (2009)PubMedCrossRef
34.
go back to reference I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, T. Sugimoto, Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur. J. Endocrinol. 160, 265–273 (2009)PubMedCrossRef I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, T. Sugimoto, Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur. J. Endocrinol. 160, 265–273 (2009)PubMedCrossRef
35.
go back to reference N. Sucunza, M.J. Barahona, E. Resmini, J.M. Fernández-Real, W. Ricart, J. Farrerons, J. Rodríguez Espinosa, A.M. Marin, T. Puig, S.M. Webb, A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J. Clin. Endocrinol. Metab. 94, 3889–3896 (2009)PubMedCrossRef N. Sucunza, M.J. Barahona, E. Resmini, J.M. Fernández-Real, W. Ricart, J. Farrerons, J. Rodríguez Espinosa, A.M. Marin, T. Puig, S.M. Webb, A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J. Clin. Endocrinol. Metab. 94, 3889–3896 (2009)PubMedCrossRef
36.
go back to reference M.C. Nevitt, B. Ettinger, D.M. Black, K. Stone, S.A. Jamal, K. Ensrud, M. Segal, H.K. Genant, S.R. Cummings, The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann. Intern. Med. 128, 793–800 (1998)PubMed M.C. Nevitt, B. Ettinger, D.M. Black, K. Stone, S.A. Jamal, K. Ensrud, M. Segal, H.K. Genant, S.R. Cummings, The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann. Intern. Med. 128, 793–800 (1998)PubMed
37.
go back to reference T. Jalava, S. Sarna, L. Pylkkänen, B. Mawer, J.A. Kanis, P. Selby, M. Davies, J. Adams, R.M. Francis, J. Robinson, E. McCloskey, Association between vertebral fracture and increased mortality in osteoporotic patients. J. Bone Miner. Res. 18, 1254–1260 (2003)PubMedCrossRef T. Jalava, S. Sarna, L. Pylkkänen, B. Mawer, J.A. Kanis, P. Selby, M. Davies, J. Adams, R.M. Francis, J. Robinson, E. McCloskey, Association between vertebral fracture and increased mortality in osteoporotic patients. J. Bone Miner. Res. 18, 1254–1260 (2003)PubMedCrossRef
38.
go back to reference S. Bossoni, G. Mazziotti, C. Gazzaruso, D. Martinelli, S. Orini, S.B. Solerte, G. Romanelli, A. Giustina, Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes. Age Ageing 37, 222–225 (2008)PubMedCrossRef S. Bossoni, G. Mazziotti, C. Gazzaruso, D. Martinelli, S. Orini, S.B. Solerte, G. Romanelli, A. Giustina, Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes. Age Ageing 37, 222–225 (2008)PubMedCrossRef
39.
go back to reference M. Sherlock, J. Ayuk, J.W. Tomlinson, A.A. Toogood, A. Aragon-Alonso, M.C. Sheppard, A.S. Bates, P.M. Stewart, Mortality in patients with pituitary disease. Endocr. Rev. 31, 301–342 (2010)PubMedCrossRef M. Sherlock, J. Ayuk, J.W. Tomlinson, A.A. Toogood, A. Aragon-Alonso, M.C. Sheppard, A.S. Bates, P.M. Stewart, Mortality in patients with pituitary disease. Endocr. Rev. 31, 301–342 (2010)PubMedCrossRef
40.
go back to reference G. Mazziotti, A. Bianchi, V. Cimino, S. Bonadonna, P. Martini, A. Fusco, L. De Marinis, A. Giustina, Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. Pituitary 11, 55–61 (2008)PubMedCrossRef G. Mazziotti, A. Bianchi, V. Cimino, S. Bonadonna, P. Martini, A. Fusco, L. De Marinis, A. Giustina, Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. Pituitary 11, 55–61 (2008)PubMedCrossRef
41.
go back to reference G. Mazziotti, T. Porcelli, M. Mormando, E. De Menis, A. Bianchi, C. Mejia, T. Mancini, L. De Marinis, A. Giustina, Vertebral fractures in males with prolactinoma. Endocrine 39, 288–293 (2011)PubMedCrossRef G. Mazziotti, T. Porcelli, M. Mormando, E. De Menis, A. Bianchi, C. Mejia, T. Mancini, L. De Marinis, A. Giustina, Vertebral fractures in males with prolactinoma. Endocrine 39, 288–293 (2011)PubMedCrossRef
Metadata
Title
Influence of diabetes mellitus on vertebral fractures in men with acromegaly
Authors
Gherardo Mazziotti
Monica Gola
Antonio Bianchi
Teresa Porcelli
Antonella Giampietro
Vincenzo Cimino
Mauro Doga
Carmine Gazzaruso
Laura De Marinis
Andrea Giustina
Publication date
01-08-2011
Publisher
Springer US
Published in
Endocrine / Issue 1/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9486-x

Other articles of this Issue 1/2011

Endocrine 1/2011 Go to the issue